Bank of America’s Haemonetics HAE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $28.9M | Buy |
512,183
+30,018
| +6% | +$1.96M | ﹤0.01% | 2077 |
|
|
2025
Q4 | $38.6M | Buy |
482,165
+147,864
| +44% | +$9.93M | ﹤0.01% | 1736 |
|
|
2025
Q3 | $16.3M | Sell |
334,301
-345,190
| -51% | -$21.4M | ﹤0.01% | 2805 |
|
|
2025
Q2 | $50.7M | Buy |
679,491
+36,259
| +6% | +$2.4M | ﹤0.01% | 1698 |
|
|
2025
Q1 | $40.9M | Buy |
643,232
+226,383
| +54% | +$15.4M | ﹤0.01% | 1769 |
|
|
2024
Q4 | $32.5M | Sell |
416,849
-82,931
| -17% | -$6.66M | ﹤0.01% | 1850 |
|
|
2024
Q3 | $40.2M | Sell |
499,780
-3,668
| -0.7% | -$296K | ﹤0.01% | 1757 |
|
|
2024
Q2 | $41.7M | Buy |
503,448
+215,356
| +75% | +$18.9M | ﹤0.01% | 1585 |
|
|
2024
Q1 | $24.6M | Buy |
288,092
+126,931
| +79% | +$9.96M | ﹤0.01% | 2078 |
|
|
2023
Q4 | $13.8M | Buy |
161,161
+17,036
| +12% | +$1.47M | ﹤0.01% | 2534 |
|
|
2023
Q3 | $12.9M | Buy |
144,125
+43,284
| +43% | +$3.86M | ﹤0.01% | 2475 |
|
|
2023
Q2 | $8.59M | Sell |
100,841
-53,594
| -35% | -$4.53M | ﹤0.01% | 2855 |
|
|
2023
Q1 | $12.8M | Buy |
154,435
+32,211
| +26% | +$2.61M | ﹤0.01% | 2570 |
|
|
2022
Q4 | $9.61M | Buy |
122,224
+31,697
| +35% | +$2.55M | ﹤0.01% | 2727 |
|
|
2022
Q3 | $6.7M | Sell |
90,527
-24,729
| -21% | -$1.78M | ﹤0.01% | 3033 |
|
|
2022
Q2 | $7.51M | Sell |
115,256
-102,238
| -47% | -$6.05M | ﹤0.01% | 2974 |
|
|
2022
Q1 | $13.8M | Buy |
217,494
+17,820
| +9% | +$969K | ﹤0.01% | 2545 |
|
|
2021
Q4 | $10.6M | Sell |
199,674
-34,857
| -15% | -$2.12M | ﹤0.01% | 2874 |
|
|
2021
Q3 | $16.6M | Sell |
234,531
-36,807
| -14% | -$2.32M | ﹤0.01% | 2342 |
|
|
2021
Q2 | $18.1M | Buy |
271,338
+20,869
| +8% | +$1.48M | ﹤0.01% | 2239 |
|
|
2021
Q1 | $27.8M | Buy |
250,469
+80,520
| +47% | +$9.96M | ﹤0.01% | 1752 |
|
|
2020
Q4 | $20.2M | Buy |
169,949
+13,759
| +9% | +$1.48M | ﹤0.01% | 1886 |
|
|
2020
Q3 | $13.6M | Buy |
156,190
+42,779
| +38% | +$3.74M | ﹤0.01% | 2023 |
|
|
2020
Q2 | $10.2M | Buy |
113,411
+37,000
| +48% | +$3.74M | ﹤0.01% | 2199 |
|
|
2020
Q1 | $7.62M | Sell |
76,411
-20,650
| -21% | -$2.24M | ﹤0.01% | 2286 |
|
|
2019
Q4 | $11.2M | Buy |
97,061
+4,359
| +5% | +$527K | ﹤0.01% | 2460 |
|
|
2019
Q3 | $11.7M | Sell |
92,702
-4,222
| -4% | -$536K | ﹤0.01% | 2344 |
|
|
2019
Q2 | $11.7M | Sell |
96,924
-4,867
| -5% | -$479K | ﹤0.01% | 2386 |
|
|
2019
Q1 | $8.9M | Sell |
101,791
-2,243
| -2% | -$204K | ﹤0.01% | 2601 |
|
|
2018
Q4 | $10.4M | Sell |
104,034
-7,182
| -6% | -$754K | ﹤0.01% | 2266 |
|
|
2018
Q3 | $12.7M | Sell |
111,216
-111,778
| -50% | -$11.6M | ﹤0.01% | 2236 |
|
|
2018
Q2 | $20M | Sell |
222,994
-154,418
| -41% | -$13M | ﹤0.01% | 1806 |
|
|
2018
Q1 | $27.6M | Sell |
377,412
-155,437
| -29% | -$10.7M | ﹤0.01% | 1505 |
|
|
2017
Q4 | $30.9M | Sell |
532,849
-323,818
| -38% | -$17.1M | 0.01% | 1439 |
|
|
2017
Q3 | $38.4M | Buy |
856,667
+200,827
| +31% | +$8.34M | 0.01% | 1355 |
|
|
2017
Q2 | $25.9M | Buy |
655,840
+145,850
| +29% | +$5.99M | 0.01% | 1514 |
|
|
2017
Q1 | $20.7M | Buy |
509,990
+75,820
| +17% | +$2.96M | ﹤0.01% | 1714 |
|
|
2016
Q4 | $17.5M | Buy |
434,170
+27,872
| +7% | +$1.05M | ﹤0.01% | 1800 |
|
|
2016
Q3 | $14.7M | Buy |
406,298
+6,944
| +2% | +$238K | ﹤0.01% | 1898 |
|
|
2016
Q2 | $11.6M | Sell |
399,354
-160,744
| -29% | -$4.86M | ﹤0.01% | 2067 |
|
|
2016
Q1 | $19.6M | Buy |
560,098
+68,112
| +14% | +$2.2M | ﹤0.01% | 1572 |
|
|
2015
Q4 | $15.9M | Buy |
491,986
+20,256
| +4% | +$657K | ﹤0.01% | 1848 |
|
|
2015
Q3 | $15.2M | Buy |
471,730
+368,763
| +358% | +$13.9M | ﹤0.01% | 1831 |
|
|
2015
Q2 | $4.26M | Buy |
102,967
+52,314
| +103% | +$2.21M | ﹤0.01% | 2734 |
|
|
2015
Q1 | $2.28M | Sell |
50,653
-21,296
| -30% | -$890K | ﹤0.01% | 3132 |
|
|
2014
Q4 | $2.69M | Buy |
71,949
+20,785
| +41% | +$761K | ﹤0.01% | 3094 |
|
|
2014
Q3 | $1.79M | Buy |
51,164
+9,979
| +24% | +$356K | ﹤0.01% | 3494 |
|
|
2014
Q2 | $1.45M | Sell |
41,185
-51,425
| -56% | -$1.72M | ﹤0.01% | 3667 |
|
|
2014
Q1 | $3.02M | Sell |
92,610
-357
| -0.4% | -$13.6K | ﹤0.01% | 2840 |
|
|
2013
Q4 | $3.92M | Buy |
92,967
+9,469
| +11% | +$390K | ﹤0.01% | 2690 |
|
|
2013
Q3 | $3.33M | Buy |
83,498
+3,878
| +5% | +$163K | ﹤0.01% | 2765 |
|
|
2013
Q2 | $3.29M | Buy |
+79,620
| New | +$3.22M | ﹤0.01% | 2678 |
|
Other funds holding HAE
VPM
VCM
RRAM
Bank of America's HAE Position: Q1 2026 in Review
Bank of America increased its Haemonetics (HAE) stake by 6.2% in Q1 2026, buying an estimated $1.96M and bringing the position to 512,183 shares worth $28.9M. The position accounts for ﹤0.01% of the portfolio, ranked #2077.
Bank of America first reported a position in HAE in Q2 2013 and has held it in 52 quarters since. The position peaked at $50.7M in Q2 2025. 324 funds tracked by Wall St. Rank hold HAE as of Q1 2026.
- Bank of America held 512,183 shares of Haemonetics worth $28.9M as of Q1 2026.
- Bank of America bought 30,018 Haemonetics shares in Q1 2026, an estimated $1.96M.
- Haemonetics made up ﹤0.01% of Bank of America's portfolio in Q1 2026, its #2077 holding.
- Bank of America first reported a position in Haemonetics in Q2 2013 and has held it in 52 quarters since.
- Bank of America's Haemonetics position peaked at $50.7M in Q2 2025.
- 324 funds tracked by Wall St. Rank held Haemonetics as of Q1 2026.
Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.